Highlights•Review summarizes the current status of colon cancer and its management
strategies.•Features nanoformulated targeted delivery of anticancer drugs for colon cancer …

The polysaccharide-based advanced drug delivery system owing to their biocompatibility,
ability to encapsulate the drug molecules in their interspaces, and ability to achieve a …

Colorectal cancer (CRC) is highly prevalent worldwide, and despite notable progress in
treatment still leads to significant morbidity and mortality. The use of nanoparticles as a drug …

Cancer theranostics represents a strategy that aims at combining diagnosis with therapy
through the simultaneous imaging and targeted delivery of therapeutics to cancer cells …

Colorectal cancer (CRC) is the third most common cancer diagnosed worldwide in human
beings. Surgery, chemotherapy, radiotherapy and targeted therapies are the conventional …

Lipid-polymer hybrid nanoparticles (LPHNPs) are emerging platforms for drug delivery
applications. In the present study, methotrexate loaded LPHNPs consisted of PLGA and …

With people's increasing awareness of diseases treatment, the researchers began to focus
on drug delivery to the exact site of action at the optimal rate. Some researchers have …

Chemotherapy as the main cancer treatment method has non-specific effects and various
side-effects. Accordingly, significant attempts have been conducted to enhance its efficacy …

In the present study, polymeric nanoparticles loaded with IRI and quercetin, a p-gp inhibitor,
were developed to target folate receptors expressed by colon cancer cells for oral targeted …

Colorectal cancer (CRC) is among the five most commonly diagnosed cancers worldwide,
constituting 6% of all cancers and the third leading cause of cancer death. CRC is the third …